تصفح Medicine Research حسب المؤلف "Danjuma, Mohammed Ibn Mas ud"
-
HCV cirrhotic patients treated with direct-acting antivirals: Detection of tubular dysfunction and resolution after viral clearance
Danjuma, Mohammed Ibn Mas’ud; AbouJabal, Bodoor; Naseralallah, Lina Mohammad Ahmad; Elzouki, Abdelnaser ( Wiley-Blackwell , 2021 , Other)Bilotti et al's1 recent excellent report on the prevalence of tubular and glomerular dysfunction in patients with HCV infection on direct-acting antiviral (DAA) agents, and their evolution following HCV clearance adds to ... -
An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
Danjuma, Mohammed Ibn Mas’ud; Naseralallah, Lina Mohammad Ahmad; AbouJabal, Bodoor; Mohamed, Mouhand Faisal; Abubeker, Ibrahim Y.; Jabbar, Layla Abdul; Elzouki, Abdelnaser... more authors ... less authors ( Springer Nature , 2021 , Article)Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rising morbidity amongst hospitalized patients. Whilst clinical protocols for the management of individual DRESS cases have been well established, ... -
Prevalence and global trends of polypharmacy in patients with chronic liver disease: A systematic review and meta-analysis
Danjuma, Mohammed Ibn Mas Ud; Naseralallah, Lina; Ansari, Soubiya; Al Shebly, Rafal; Elhams, Mohammed; Alshamari, Manwa; Kordi, Ahmad; Fituri, Nuha; Almohammed, Ahmed... more authors ... less authors ( Wolters Kluwer Health , 2023 , Article)Background: Despite its central role in drug metabolism, the exact prevalence estimates and factors affecting global trends of polypharmacy in patients with chronic liver disease (CLD) have remained unexamined. The aim of ... -
What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review
Azhar, Al-Khulaifi; Khatib, Malkan; Ali, Elrazi; Ali, Mohamed Yousif; Danjuma, Mohammed Ibn-Mas'ud ( Elsevier , 2023 , Article)PurposePolypharmacy presents an increasing therapeutic challenge for physicians managing patients with chronic kidney disease (CKD). However, there is a lack of consensus regarding the specific medication count threshold ...